Pre-Open Stock Movers 01/28: (CLFD) (PRVB) (TEAM) Higher; (HOOD) (WDC) (CVX) Lower (more...)

Pre-Open Movers:

Robinhood (NASDAQ: HOOD) 11.6% LOWER; reported Q4 EPS of ($0.49), $0.04 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $363 million versus the consensus estimate of $362.1 million. Robinhood sees Q1 2022 revenue of less than $340 million, versus the consensus of $448.2 million.

Clearfield, Inc. (NASDAQ: CLFD) 10.2% HIGHER; Revenue For First Fiscal Quarter Grew 89% to Record $51 Million, Driven by 81% Growth in Community Broadband Revenue Compared to the Same Year-Ago Quarter.

Provention Bio, Inc. (Nasdaq: PRVB) 10% HIGHER; announced its intent to resubmit the teplizumab Biologics License Application (BLA) for the delay of clinical type 1 diabetes in at-risk individuals following its Type B pre-BLA resubmission meeting with the U.S. Food and Drug Administration (FDA).

Atlassian (NASDAQ: TEAM) 6.9% HIGHER; reported Q2 EPS of $0.50, $0.11 better than the analyst estimate of $0.39. Revenue for the quarter came in at $689 million versus the consensus estimate of $641.32 million. Atlassian sees Q3 2022 EPS of $0.29-$0.31, versus the consensus of $0.40. Atlassian sees Q3 2022 revenue of $690-750 million, versus the consensus of $663.02 million.

Visa (NYSE: V) 5% HIGHER; reported Q1 EPS of $1.81 $0.11 better than the analyst estimate of $1.70. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.79 billion.

Affirm Holdings Inc. (NASDAQ: AFRM) 4.2% HIGHER; DA Davidson upgraded from Hold to Buy with a price target of $75.00.

Chevron (NYSE: CVX) 4% LOWER; reported Q4 EPS of $2.56, $0.43 worse than the analyst estimate of $2.99. Revenue for the quarter came in at $48.13 billion versus the consensus estimate of $44.52 billion.

Kroger (NYSE: KR) 3.9% LOWER; Citi downgraded from Neutral to Sell with a price target of $42.00 (from $47.00).

Apple (NASDAQ: AAPL) 3.3% HIGHER; reported Q1 EPS of $2.10, $0.21 better than the analyst estimate of $1.89. Revenue for the quarter came in at $123.9 billion versus the consensus estimate of $118.28 billion.

Mondelez (NASDAQ: MDLZ) 2.7% LOWER; reported Q4 EPS of $0.71, $0.02 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $7.66 million versus the consensus estimate of $7.6 million.

You May Also Be Interested In

• Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
• Snap (SNAP), Meta (META) gain as House orders sale or ban of TikTok
• AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab